These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7424996)

  • 1. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
    Kauppila A; Hartikainen-Sorri AL; Jänne O; Tuimala R; Järvinen PA
    Am J Obstet Gynecol; 1980 Oct; 138(4):404-8. PubMed ID: 7424996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex steroid hormone concentrations in preterm labour and the outcome of treatment with ritodrine.
    Hanssens MC; Selby C; Symonds EM
    Br J Obstet Gynaecol; 1985 Jul; 92(7):698-702. PubMed ID: 4016029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL; Kauppila A; Tuimala R
    Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma steroid hormones during treatment of preterm labour with ritodrine-HCl.
    Hanssens MC; Selby C; Filshie GM; Gilbert BJ; Symonds EM
    Br J Obstet Gynaecol; 1983 Sep; 90(9):847-53. PubMed ID: 6615742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW; Lee PA; Zachary AS; Calhoun S; Migeon CJ
    Obstet Gynecol; 1979 Oct; 54(4):412-8. PubMed ID: 492618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of premature labor: a multicenter comparison of ritodrine and ethanol.
    Lauersen NH; Merkatz IR; Tejani N; Wilson KH; Roberson A; Mann LI; Fuchs F
    Am J Obstet Gynecol; 1977 Apr; 127(8):837-45. PubMed ID: 851140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
    Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M
    Am J Obstet Gynecol; 1985 Mar; 151(5):574-7. PubMed ID: 3976757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.
    Hauth JC; Gilstrap LC; Brekken AL; Hauth JM
    Am J Obstet Gynecol; 1983 May; 146(2):187-90. PubMed ID: 6682631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast engorgement and galactorrhea after preventing premature contractions with ritodrine.
    Shalev J; Frankel Y; Eshkol A; Serr DM
    Gynecol Obstet Invest; 1984; 17(4):190-3. PubMed ID: 6724348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of uterine contractions with the use of tocolytic agents (ritodrine). I. Treatment of threatened premature labor].
    Colombo PA; Pittino R; Quaranta S; Sapuppo R
    Ann Ostet Ginecol Med Perinat; 1979; 100(3):187-203. PubMed ID: 475231
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ritodrine in the treatment of threatened premature labor. Effects of gas tension and electrolyte balance].
    Qvist N; Sørensen J; Holmskov A
    Ugeskr Laeger; 1983 Jul; 145(27):2080-2. PubMed ID: 6412411
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic effects of intramuscular and oral administration of ritodrine in pregnancy.
    Schreyer P; Caspi E; Snir E; Herzianu E; User P; Gilboa Y; Zaidman JL
    Obstet Gynecol; 1981 Jun; 57(6):730-3. PubMed ID: 7231825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature rupture of the membranes and Ritodrine treatment.
    Neldam S; Osler M
    Acta Obstet Gynecol Scand; 1983; 62(2):135-9. PubMed ID: 6346781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of premature labor with ritodrine: a randomized controlled study.
    Spellacy WN; Cruz AC; Birk SA; Buhi WC
    Obstet Gynecol; 1979 Aug; 54(2):220-3. PubMed ID: 379722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-mimetics in the treatment of threatened premature labor (personal experience in 41 cases treated with ritodrine)].
    Vallone N; Cusimano R; Di Stefano S; Ferraro G; Moscarelli G; Pagano G
    Ann Ostet Ginecol Med Perinat; 1979; 100(3):181-6. PubMed ID: 38728
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of LU 52 (ritodrine HC1) in threatened premature labor].
    Zinelli G; Debiasi D; Panni R; Parolari G
    Minerva Ginecol; 1976 Nov; 28(11):925-45. PubMed ID: 1012585
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ritodrine in the treatment of premature labor].
    Gagliardi L; Mattone PG; La Vista A; Bagnoli M
    Minerva Ginecol; 1975 Dec; 27(12):1005-25. PubMed ID: 778676
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: Prophylaxis of threatened premature labor. Clinical results in a prospective comparative study with ritodrine and buphenine].
    Richter R; Hammacher K; Hinselmann M
    Gynakol Rundsch; 1975; 15 suppl 1():58-9. PubMed ID: 1241571
    [No Abstract]   [Full Text] [Related]  

  • 20. Physiologic and biochemical effects of ritodrine therapy on the mother and perinate.
    Hancock PJ; Setzer ES; Beydoun SN
    Am J Perinatol; 1985 Jan; 2(1):1-6. PubMed ID: 3921037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.